Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
Clinical trial NCT05990452 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05990452
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2026-09-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.